DELIVER May Demystify Med Therapy in HF With Improved LVEF

Should HF with improved LVEF be treated more like HFrEF or HFpEF? There are scant clinical trial data to help answer that, but a post-hoc analysis from a major trial may shed some light.

Related Keywords

Maryland ,United States ,Glasgow ,Glasgow City ,United Kingdom ,National Harbor ,Scotland ,America ,John Gf Cleland , ,University Of Glasgow Institute Health ,Heart Failure Society Of America ,University Of Minnesota ,Consistently Greater Than ,Heart Failure Society ,Scientific Meeting ,Glasgow Institute ,